Yu-Ching Teng

Yu-Ching Teng

Auto-generated profile, based on publicly available information

Yu-Ching Teng

Cecil H. and Ida Green Center for Reproductive Biology Sciences and the Division of Basic Research, Department of Obstetrics and Gynecology, Children's Medical Center Research Institute, Hamon Center for Regenerative Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2012 in Cell Reports
Verified
Journal Article
Open access
CHChih-Hung Hsu
Chih-Hung Hsu
KPKai-Lin Peng
Kai-Lin Peng
MKMing-Lun Kang
Ming-Lun Kang
YCYi-Ren Chen
Yi-Ren Chen
YYYu-Chih Yang
Yu-Chih Yang
LJLi-Jung Juan
Li-Jung Juan
Tumor suppressor gene silencing through cytosine methylation contributes to cancer formation. Whether DNA demethylation enzymes counteract this oncogenic effect is unknown. Here, we show that TET1, a dioxygenase involved in cytosine demethylation, is downregulated in prostate and breast cancer tissues. TET1 depletion facilitates cell invasion, tumor growth, and cancer metastasis in prostate xenograft models and correlates with poor survival rates in breast cancer patients. Consistently, enforced expression of TET1 reduces cell invasion and breast xenograft tumor formation. Mechanistically, TET1 suppresses cell invasion through its dioxygenase and DNA binding activities. Furthermore, TET1 maintains the expression of tissue inhibitors of metalloproteinase (TIMP) family proteins 2 and 3 by inhibiting their DNA methylation. Concurrent low expression of TET1 and TIMP2 or TIMP3 correlates with advanced node status in clinical samples. Together, these results illustrate a mechanism by which TET1 suppresses tumor development and invasion partly through downregulation of critical gene methylation.

13 January 2014 in Proceedings of the National Academy of Sciences of the United States of America
Verified
Journal Article
Closed access
CCChi-Shuen Chu
Chi-Shuen Chu
PLPei-Wen Lo
Pei-Wen Lo
YYYi-Hsien Yeh
Yi-Hsien Yeh
PHPang-Hung Hsu
Pang-Hung Hsu
SPShih-Huan Peng
Shih-Huan Peng
LJLi-Jung Juan
Li-Jung Juan
Significance: The present study identifies a cross-talk of two important posttranslational modifications, revealing that enhancer of zeste homolog 2 (EZH2) O-GlcNAcylation (GlcNac, N -acetylglucosamine) at serine 75 is required for EZH2 protein stability and therefore facilitates the histone H3 trimethylation at K27 to form H3K27me3. The finding is significant because both O-linked GlcNAc transferase-mediated O-GlcNAcylation and EZH2-mediated H3K27me3 formation play a pivotal role in development, and their up-regulation is believed to participate in tumor malignancy. The identification of O-linked GlcNAc transferase association with the polycomb repressive complex 2 (PRC2) further provides a new approach to regulate PRC2 function.

31 May 2019 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
SMSara Martire
Sara Martire
AGAishwarya A. Gogate
Aishwarya A. Gogate
AWAmanda Whitmill
Amanda Whitmill
ATAmanuel Tafessu
Amanuel Tafessu
JNJennifer Nguyen
Jennifer Nguyen
LBLaura A. Banaszynski
Laura A. Banaszynski

31 July 2013 in Cancer Research
Verified
Journal Article
Open access
PDF file
YTYu-Ching Teng
Yu-Ching Teng
CLCheng-Feng Lee
Cheng-Feng Lee
YLYing-Shiuan Li
Ying-Shiuan Li
YCYi-Ren Chen
Yi-Ren Chen
PHPei-Wen Hsiao
Pei-Wen Hsiao
LJLi-Jung Juan
Li-Jung Juan
The retinoblastoma binding protein RBP2 (KDM5A) is a histone demethylase that promotes gastric cancer cell growth and is enriched in drug-resistant lung cancer cells. In tumor-prone mice lacking the tumor suppressor gene RB or MEN1, genetic ablation of RBP2 can suppress tumor initiation, but the pathogenic breadth and mechanistic aspects of this effect relative to human tumors have not been defined. Here, we approached this question in the context of lung cancer. RBP2 was overexpressed in human lung cancer tissues where its depletion impaired cell proliferation, motility, migration, invasion, and metastasis. RBP2 oncogenicity relied on its demethylase and DNA-binding activities. RBP2 upregulated expression of cyclins D1 and E1 while suppressing the expression of cyclin-dependent kinase inhibitor p27 (CDKN1B), each contributing to RBP2-mediated cell proliferation. Expression microarray analyses revealed that RBP2 promoted expression of integrin-β1 (ITGB1), which is implicated in lung cancer metastasis. Mechanistic investigations established that RBP2 bound directly to the p27, cyclin D1, and ITGB1 promoters and that exogenous expression of cyclin D1, cyclin E1, or ITGB1 was sufficient to rescue proliferation or migration/invasion, respectively. Taken together, our results establish an oncogenic role for RBP2 in lung tumorigenesis and progression and uncover novel RBP2 targets mediating this role. Cancer Res; 73(15); 4711–21. ©2013 AACR.

12 February 2008 in Nature Structural & Molecular Biology
Verified
Journal Article
Closed access
PDF file
STShengjiang Tu
Shengjiang Tu
YTYu-Ching Teng
Yu-Ching Teng
CYChunhua Yuan
Chunhua Yuan
YWYing-Ta Wu
Ying-Ta Wu
MCMeng-Yu Chan
Meng-Yu Chan
MTMing-Daw Tsai
Ming-Daw Tsai

1 March 2005 in Viral Immunology
Verified
Journal Article
Closed access
YTYu-Ching Teng
Yu-Ching Teng
YCYen-Ting Chen
Yen-Ting Chen
YCYi-Yun Cheng
Yi-Yun Cheng
SHShan-Ling Hung
Shan-Ling Hung
Interleukin (IL)–6 is an important proinflammatory and immunoregulatory cytokine expressed by various cells. This study examined the production of IL-6 by human gingival keratinocytes and gingival fibroblasts following herpes simplex virus (HSV) infection. Virus-cell interactions responsible for IL-6 induction by HSV-1 were determined. The amounts of IL-6 secreted by primary human gingival keratinocytes and gingival fibroblasts were determined using enzyme-linked immunosorbent assay. IL-6 expression in gingival fibroblasts was also determined using immunofluorescence staining. To further delineate the viral requirements for this induction, gingival fibroblasts were treated with antibody-neutralized viruses, UV- or heat-inactivated viruses or viral glycoprotein D of HSV-1 (gD-1). The results showed that infection of gingival fibroblasts, but not gingival keratinocytes, with HSV-1 induced production of IL-6. This modulation was blocked by neutralizingantibodies against HSV-1, suggesting that HSV-1 is required for this induction. Moreover, this induction was not abrogated when virus infectivity was destroyed by UV irradiation or heat, indicating that a complete viral life cycle is not required. Further studies showed that gD-1 alone was able to induce IL-6 secretion in gingival fibroblasts. Collectively, our data suggest that HSV-1 infection of gingival fibroblasts up-regulates production of IL-6 through a mechanism involving the interaction of gD-1 with cellular receptors.